Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer
Piccart, M.J ; Cardoso, F ; Atalay, G
European journal of cancer (1990), 2002-11, Vol.38, p.52-54 [Periódico revisado por pares]England: Elsevier Ltd
Texto completo disponível